SCHEDULE 13GAccepted Aug 10, 8:30 PM ET
Aspire Biopharma Holdings, Inc. SCHEDULE 13G
Accepted (ET)
8:30 PM
Aug 10, 2026
Filed
Aug 10, 2026
Documents
1
Size
6.5 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.